Skip to main content

Events

Neuroscience Meet Up - August 5

The Neuroscience Meet Up is a casual, friendly monthly event facilitating interdisciplinary conversations between University of Missouri researchers at all levels. Please forward this event to anyone interested: students, faculty or staff within your groups.

For questions about this event and to be added to the monthly calendar invite, please reach out to Smita Saxena at smitasaxena@health.missouri.edu.

“SMN-Independent Amelioration of Spinal Muscular Atrophy by Pharmacological Inhibition of JNK”

Presented by: 
Laxman D. Gangwani, MSc, MTech, PhD
Professor, Department of Pathobiology and Integrative Biomedical Sciences (PIBS)
Principal Investigator, Bond Life Sciences Center

Date: August 5, 2025, 4:30-6:00 p.m.

Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room

To be added to the monthly calendar event, email Smita Saxena.

 

Speaker

Laxman Gangwani Portrait
Laxman Gangwani, PhD

The focus of the Gangwani Lab research program is to understand the molecular basis of neurodegeneration associated with the pathogenesis of neurological disorders, including Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD). Current research projects in the lab include: 1) Identification of modifier genes and validation using in vitro (patient derived cell-based models) and in vivo (mouse models) methods, including role of zinc finger protein 1 (ZPR1) as a protective modifier of ALS4. 2) The molecular mechanism of R-loop metabolism and the role of R-loops in genomic integrity and neurodegeneration. 3) Testing of small molecule drug compounds (JNK inhibitors) in SMA mouse model to develop SMN-independent treatment for SMA. 4) Impact of alteration in R-loop levels and genomic instability on the development of AD or AD-related dementia (ADRD)-like disease in a mouse model. 5) Study of biochemical functions of protein-protein complexes such as ZPR1-EF1A (translational elongation factor 1A) and ZPR1-Senataxin using newly created state-of-the-art mouse models to disrupt protein-protein interactions in specific cell types, including neurons. 6) Study of ZPR1 functions in R-loop metabolism, DNA Replication and genomic integrity using yeast model system in collaboration with Branzei lab (Institute of Molecular Oncology, Milan, Italy). The basic science research data are utilized for developing molecular and translational medicine approaches such as genetic (gene therapy) and pharmacological (small molecule drug compounds) methods to conduct pre-clinical studies using animal disease models.

 

Research Interests

Molecular Genetics, Neuron Biology, including Neurodegeneration and Neuron Regeneration, Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), Transcription-coupled R-loops, DNA Damage and Repair, RNA Biogenesis, Molecular and Translational Medicine, Genetically Modified Yeast Models, Mouse Models of Neurological Diseases

 

 

Neuroscience Meet Up Logo